Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 31, 2019.

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Celgene Corp., consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Net income (loss)
Depreciation
Amortization
Impairment charges
Deferred income taxes
Change in value of contingent consideration and success payments
Gain on sale of business
Net (gain) loss on sales of debt securities available-for-sale
Fair value adjustments on equity investments
Share-based compensation expense
Share-based employee benefit plan expense
Derivative instruments
Other, net
Accounts receivable
Inventory
Other operating assets
Accounts payable and other operating liabilities
Income tax payable
Payment of contingent consideration
Deferred revenue
Change in current assets and liabilities, excluding the effect of acquisitions and disposals
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Net cash provided by (used in) operating activities
Proceeds from sales of debt securities available-for-sale
Purchases of debt securities available-for-sale
Capital expenditures
Proceeds from sales of equity investment securities
Purchases of equity investment securities
Payments for acquisition of businesses, net of cash acquired
Payment for acquisition of intangible asset
Other
Net cash (used in) provided by investing activities
Payment for treasury shares
Proceeds from short-term borrowing
Principal repayments on short-term borrowing
Proceeds from issuance of long-term debt
Principal repayments on current portion of long-term debt
Net proceeds (payments) from common equity put options
Payment of contingent consideration
Net proceeds from share-based compensation arrangements
Excess tax benefit from share-based compensation arrangements
Net cash provided by (used in) financing activities
Effect of currency rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents

Based on: 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-K (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31).


Net income (loss)
The net income showed a generally positive trend with fluctuations over the periods. It increased from 280 million USD in March 2014 to a peak of 1691 million USD by September 2019. Several quarters showed declines, including notable losses in September 2015 (-34 million USD) and December 2017 (-81 million USD), but the overall direction was upward towards the end of the period.
Depreciation
Depreciation expenses steadily increased from 26 million USD in early 2014 to 48 million USD by late 2019, reflecting a gradual growth in capital asset bases or changes in asset utilization.
Amortization
Amortization displayed considerable volatility, with large spikes such as 198 million USD in September 2014 and 408 million USD in December 2016. Despite fluctuations, it averaged higher levels in the later periods, suggesting increased intangible asset amortization.
Impairment charges
Impairment charges were sporadic and notably significant in June 2017 with 1628 million USD, indicating a major write-down during this quarter. Other impairment amounts were minor or absent.
Deferred income taxes
This item fluctuated between positive and negative values, with a marked extreme negative value of -1135 million USD in December 2017, implying substantial tax adjustments or losses deferred during that quarter.
Change in value of contingent consideration and success payments
The values were inconsistent with both positive and negative swings, including an extreme negative value of -1425 million USD in December 2017, likely associated with settlement or valuation changes of contingent liabilities.
Gain on sale of business
There was a recorded loss of -38 million USD in March 2016, with no other significant entries, implying a single event impacting earnings that quarter.
Net (gain) loss on sales of debt securities available-for-sale
The data shows small gains and losses across periods without a clear trend, indicating routine investment portfolio adjustments.
Fair value adjustments on equity investments
Significant negative adjustment (-959 million USD) appeared in June 2017 followed by positive adjustments reaching 513 million USD in December 2018, highlighting substantial valuation changes in equity investments.
Share-based compensation expense
This expense generally increased from 104 million USD in early 2014 to a peak of 284 million USD in June 2018, then declined but remained elevated, reflecting growing employee compensation through equity grants.
Accounts receivable
Accounts receivable changes showed high variability, with large negative impacts especially in March 2019 (-271 million USD), suggesting fluctuations in collections or sales timing impacting working capital.
Inventory
Inventory changes were mostly negative or minor positive amounts, showing occasional buildup or reduction but without a sustained trend.
Other operating assets
This category exhibited significant volatility; notably large negative impacts (-309 million USD in December 2014 and -213 million USD in June 2017) alternated with positive swings, indicating changes in miscellaneous operational asset accounts.
Accounts payable and other operating liabilities
The figures showed high variability with large positive and negative swings, highlighting fluctuating obligations. For instance, large negative cash effect of -365 million USD in March 2016 was offset by a strong positive movement of 584 million USD the following quarter.
Income tax payable
This liability account fluctuated largely, with a marked increase to 2064 million USD in December 2017, signaling a significant tax position adjustment.
Deferred revenue
Deferred revenue showed small and inconsistent changes with no clear pattern, indicating stable contract liability management.
Net cash provided by (used in) operating activities
Operating cash flows were mostly positive and showed overall growth from 557 million USD in March 2014 to 2172 million USD by September 2019, with some intermittent dips, reflecting strong cash generation capability.
Net cash (used in) provided by investing activities
Investing activities mostly reflected cash use, with a few quarters showing positive net inflows (e.g., 338 million USD in March 2015 and 1098 million USD in December 2017). Large cash outflows were evident in quarters with acquisition activity, such as -6138 million USD in September 2015 and -5658 million USD in March 2018.
Net cash provided by (used in) financing activities
Financing cash flows fluctuated significantly, featuring both large inflows and outflows. Notable outgoing cash included -2908 million USD in December 2017 related to treasury shares buybacks, while several quarters recorded inflows from debt issuance and treasury transactions.
Capital expenditures
Capital expenditures generally ranged between 25 and 141 million USD per quarter, with no strong trend, indicating stable investment in property and equipment.
Overall cash and equivalents
Cash and cash equivalents showed periods of both increase and decrease. Particularly large decreases occurred in March 2018 (-4194 million USD) and June 2018 (-1316 million USD), while strong increases recurred toward late 2018 and 2019, ending with a 2390 million USD increase in September 2019, supporting liquidity growth.